CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Agreement ended · Results of operations
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Other events
Page 3 of 42 · 833 filings